Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Document › Details

MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan.

Organisations Organisation MolMed S.p.A. (MLMD.MI)
  Group Asahi Glass (AGC) (Group)
  Organisation 2 Autolus Therapeutics Ltd.
  Today Autolus Therapeutics plc (Nasdaq: AUTL)
  Group Autolus Therapeutics plc (Nasdaq: AUTL)
Products Product contract manufacturing (biologicals)
  Product 2 Zalmoxis®
Persons Person Palmisano, Riccardo (MolMed 201606 CEO)
  Person 2 Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl)
     


   
Record changed: 2020-03-25

Advertisement

Picture [iito] – Putting Information into Context 650x65px

More documents for Asahi Glass (AGC) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px




» top